Barrons

 

In Barron's Feb. 6, 2012, issue:

For 5-year performance, Delaware Investments ranked 5th of 53 firms.

For 10-year performance, Delaware Investments ranked 2nd of 45 firms.

In specific asset categories, out of 58 fund families, Delaware Investments ranked:

2nd
U.S.-Equity Funds
4th
World-Equity Funds

For the 1-year period, ended Dec. 31, 2011.

Learn more about Delaware Investments.

Delaware Investments offers equity and fixed income solutions for institutional and individual investors:

  • U.S. growth equity
  • U.S. value equity
  • Multi-asset
  • U.S. core equity
  • Income and growth
  • Global/international equity
  • Alternative/specialty
  • Taxable fixed income
  • National municipal fixed income
  • State municipal fixed income

We offer these solutions across many different vehicles to suit the needs of myriad clients:

  • Institutional separate accounts
  • Mutual funds
  • Pooled trust funds
  • Variable insurance products
  • Separately managed accounts
  • Collective investment trusts

At Delaware Investments, successful global asset management is a product of focused expertise. Our dedicated fixed income and equity teams have delivered thoughtful investment solutions and durable long-term performance for more than 80 years. 

Take a closer look at Delaware Investments — where performance is our passion.

Barron’s is a trademark of Dow Jones, L.P. all rights reserved. Barron’s rankings are based on asset-weighted returns in five categories: U.S. equity, world equity, mixed equity, taxable bonds and tax-exempt bonds. View Barron's complete methodology. Visit www.barrons.com for the full article.

Past performance does not guarantee future results.

Investing involves risk, including the possible loss of principal.

Carefully consider the Funds' investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Funds' prospectuses and, if available, their summary prospectuses, which may be obtained by visiting the fund literature page or calling 877 693-3546 fund literature page or calling 800 523-1918. Investors should read the prospectus and, if available, the summary prospectus carefully before investing.